EPHA2 and ovarian cancer: In adult tissue, EphA2 is found to be expressed smaller amount in epithelial cells, but excessive expression almost ten-fold higher is seen in various tumors, including GBM patient tumor (61%), ovarian cancer (76%), prostate adenocarcinoma (85%), gastric cancer (77%), hepatocellular carcinoma, colorectal carcinoma and endometrial cancer [264,265,266,267,268,269,270,271,272,273].